A- A A+

Maternal prescribed opioid analgesic use during pregnancy and associations with adverse birth outcomes: A population-based study.

Sujan AC, Quinn PD, Rickert ME, Wiggs KK, Lichtenstein P, Larsson H, et al. (2019) 

PLoS Med 16(12): e1002980. doi.org/10.1371/journal.pmed.1002980

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002980

Opioid use disorder in pregnancy.

Harter K.

Ment Health Clin. 2019 Nov 27;9(6):359-372. doi: 10.9740/mhc.2019.11.359.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881108/

Antepartum Drug Dependence and Pregnancy- or Birth-related Complications: A Cross-sectional Study of 19 Million Inpatients.

Ahmad N, Robert CA, Jampa A, Ashraf S, Patel RS.

Cureus. 2019 Nov 10;11(11):e6117. doi: 10.7759/cureus.6117.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903893/

Naltrexone use in pregnancy: a time for change.

Caritis SN, Venkataramanan R.

Am J Obstet Gynecol. 2020 Jan;222(1):1-2. doi: 10.1016/j.ajog.2019.08.041. 

https://doi.org/10.1016/j.ajog.2019.08.041

Life-long impairment of glucose homeostasis upon prenatal exposure to psychostimulants.

Korchynska S, Krassnitzer M, Malenczyk K, Prasad RB, Tretiakov EO, Rehman S, Cinquina V, Gernedl V, Farlik M, Petersen J, Hannes S, Schachenhofer J, Reisinger SN, Zambon A, Asplund O, Artner I, Keimpema E, Lubec G, Mulder J, Bock C, Pollak DD, Romanov RA, Pifl C, Groop L, Hökfelt TG, Harkany T.

EMBO J. 2019 Nov 21:e100882. doi: 10.15252/embj.2018100882.

https://www.embopress.org/doi/full/10.15252/embj.2018100882

Preventing the Use of Marijuana: Focus on Women and Pregnancy

This guide supports health care providers, systems, and communities seeking to prevent marijuana use among pregnant women. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources. (SAMHSA - Substance Abuse and Mental Health Services Administration, USA, Dezember 2019)

https://store.samhsa.gov/system/files/pep19-pl-guide-2.pdf

Buprenorphine and Naloxone Versus Buprenorphine for Opioid Use Disorder in Pregnancy: A Cohort Study.

Mullins N, Galvin SL, Ramage M, Gannon M, Lorenz K, Sager B, Coulson CC.

J Addict Med. 2019 Sep 17. doi: 10.1097/ADM.0000000000000562.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31567599

The Impact of Hepatitis C Virus Infection on Buprenorphine Dose in Pregnancy.

McDowell ML, Tonismae TR, Slaven JE, Abernathy MP, Shanks AL, Benjamin TD, Quinney SK.

Am J Perinatol. 2019 Oct 26. doi: 10.1055/s-0039-1698838.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31655490

U.S. Surgeon General’s Advisory: Marijuana Use and the Developing Brain

I, Surgeon General VADM Jerome Adams, am emphasizing the importance of protecting our Nation from the health risks of marijuana use in adolescence and during pregnancy. Recent increases in access to marijuana and in its potency, along with misperceptions of safety of marijuana endanger our most precious resource, our nation’s youth. (Office of the Surgeon General, USA, November 2019)

https://www.hhs.gov/surgeongeneral/reports-and-publications/addiction-and-substance-misuse/advisory-on-marijuana-use-and-developing-brain/index.html

Educational achievement at age 9.5 years of children born to mothers maintained on methadone during pregnancy.

Lee SJ, Woodward LJ, Henderson JMT (2019) 

PLoS ONE 14(10): e0223685. doi.org/10.1371/journal.pone.0223685

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0223685

Use of Kratom, an Opioid-like Traditional Herb, in Pregnancy.

Smid MC, Charles JE, Gordon AJ, Wright TE.

Obstet Gynecol. 2018 Oct;132(4):926-928. doi: 10.1097/AOG.0000000000002871.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30204686

State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.

Kroelinger CD, Rice ME, Cox S, et al. 

MMWR Morb Mortal Wkly Rep 2019;68:777–783. DOI: doi.org/10.15585/mmwr.mm6836a1

https://www.cdc.gov/mmwr/volumes/68/wr/mm6836a1.htm

Prenatal Exposure to Methamphetamine: Up-Regulation of Brain Receptor Genes.

Zoubková H, Tomášková A, Nohejlová K, Černá M, Šlamberová R.

Front Neurosci. 2019 Aug 1;13:771. doi: 10.3389/fnins.2019.00771.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686742/

Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines [Internet].

Edge R, Butcher R.

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 May 9. PMID: 31479216

https://www.ncbi.nlm.nih.gov/books/NBK545816/

Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth.

Margulis AV, Hernandez-Diaz S, McElrath T, Rothman KJ, Plana E, Almqvist C, et al. (2019) 

PLoS ONE 14(8): e0214180. doi.org/10.1371/journal.pone.0214180

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214180

Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway.

Handal M, Nechanská B, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Mravčík V.

Pharmacol Res Perspect. 2019 Aug 14;7(5):e00501. doi: 10.1002/prp2.501.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694203/

Association of Maternal Use of Benzodiazepines and Z-Hypnotics During Pregnancy With Motor and Communication Skills and Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers.

Lupattelli A, Chambers CD, Bandoli G, Handal M, Skurtveit S, Nordeng H.

JAMA Netw Open. 2019 Apr 5;2(4):e191435. doi: 10.1001/jamanetworkopen.2019.1435. Erratum in: JAMA Netw Open. 2019 May 3;2(5):e194291. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450329/

Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study.

Brandlistuen RE, Ystrom E, Hernandez-Diaz S, Skurtveit S, Selmer R, Handal M, et al. (2017) 

PLoS ONE 12(7): e0181042. doi.org/10.1371/journal.pone.0181042

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181042

Opioids Affect the Fetal Brain: Reframing the Detoxification Debate.

Caritis SN, Panigrahy A.

Am J Obstet Gynecol. 2019 Jul 16. pii: S0002-9378(19)30906-8. doi: 10.1016/j.ajog.2019.07.022.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31323217

Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.

Nguyen L, Lander LR, O'Grady KE, Marshalek PJ, Schmidt A, Kelly AK, Jones HE.

Am J Addict. 2018 Mar;27(2):92-96. doi: 10.1111/ajad.12687. 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929133/

Maternal buprenorphine treatment during pregnancy and maternal physiology.

Jansson LM, Velez ML, McConnell K, Milio L, Spencer N, Jones H, DiPietro JA.

Drug Alcohol Depend. 2019 May 31;201:38-44. doi: 10.1016/j.drugalcdep.2019.03.018. 

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/31176949

Impact of prenatal exposure to benzodiazepines and z-hypnotics on behavioral problems at 5 years of age: A study from the Norwegian Mother and Child Cohort Study.

Sundbakk LM, Wood M, Gran JM, Nordeng H (2019) 

PLoS ONE 14(6): e0217830. doi.org/10.1371/journal.pone.0217830

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0217830

Substance Use In Pregnancy.

Prince MK, Ayers D.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 18.

https://www.ncbi.nlm.nih.gov/books/NBK542330/

Medications to Treat Opioid Use During Pregnancy – An info sheet for providers

This information sheet, for practitioners, explains the importance of concurrent treatment of OUD with prenatal/postpartum care and the importance of providing the materials to clients. (SAMSHA, USA, April 2019)

https://store.samhsa.gov/system/files/pre_pregnancy_info_sheet_042219_508_0.pdf

Pregnancy Planning for Women Treated for Opioid Use Disorder 

This fact sheet is for women who are pregnant or of childbearing age with an opioid use disorder. (SAMHSA, USA, April 2019)

https://store.samhsa.gov/system/files/pre_pregnancy_factsheet_041919_508.pdf

Implications of perinatal buprenorphine exposure on infant head circumference at birth.

O'Connor A, O'Brien L, Watson L.

J Matern Fetal Neonatal Med. 2019 Mar 25:1-81. doi: 10.1080/14767058.2019.1599352.

Abstract

https://www.ncbi.nlm.nih.gov/pubmed/30905231

Cannabis in der Schwangerschaft könnte Psychoserisiko der Kinder erhöhen

St. Louis/Missouri – Kinder, deren Mütter einen Cannabiskonsum in der Schwangerschaft angegeben hatten, wiesen in einer prospektiven Kohortenstudie in JAMA Psychiatry(2019; doi: 10.1001/jamapsychiatry.2019.0076) im Alter von etwa 10 Jahren eine erhöhte Neigung zu psychotischen Symptomen auf. (aerzteblatt.de, 28.03.2019)

https://www.aerzteblatt.de/nachrichten/101997/Cannabis-in-der-Schwangerschaft-koennte-Psychoserisiko-der-Kinder-erhoehen

Schon eine Zigarette am Tag in der Schwangerschaft verdoppelt das Risiko auf einen Krippentod

Seattle – Rauchen während der Schwangerschaft könnte eine wichtige Ursache für den Krippentod (SIDS) sein. In einer US-Studie in Pediatrics(2019; doi: 10.1542/peds.2018-3325) war bereits für eine tägliche Zigarette ein erhöhtes Risiko nachweisbar, das dosisabhängig anstieg. (aerzteblatt.de, 13.03.2019)

https://www.aerzteblatt.de/nachrichten/101585/Schon-eine-Zigarette-am-Tag-in-der-Schwangerschaft-verdoppelt-das-Risiko-auf-einen-Krippentod

Maternal Smoking Before and During Pregnancy and the Risk of Sudden Unexpected Infant Death

Tatiana M. Anderson, Juan M. Lavista Ferres, Shirley You Ren, Rachel Y. Moon, Richard D. Goldstein, Jan-Marino Ramirez, Edwin A. Mitchell

Pediatrics Mar 2019, e20183325; DOI: 10.1542/peds.2018-3325 

https://pediatrics.aappublications.org/content/early/2019/03/07/peds.2018-3325

Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy.

Committee on Obstetric Practice.

Obstet Gynecol. 2017 Aug;130(2):e81-e94. doi: 10.1097/AOG.0000000000002235.

https://journals.lww.com/greenjournal/Fulltext/2017/08000/Committee_Opinion_No__711___Opioid_Use_and_Opioid.57.aspx